Comparative acute blood pressure reduction from intravenous fenoldopam mesylate versus sodium nitroprusside in severe systemic hypertension

This publication has 13 references indexed in Scilit:

• Selective dopamine-1 agonist therapy in severe hypertension: Effects of intravenous fenoldopam
  Journal of the American College of Cardiology, 1988
• Intravenous fenoldopam in heart failure: Comparing the hemodynamic effects of dopamine1 receptor agonism with nitroprusside
  American Heart Journal, 1988
• Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1‐receptor agonist, in hypertensive patients.
  British Journal of Clinical Pharmacology, 1988
• Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine1 agonist fenoldopam.
  Circulation, 1987
• The action of a dopamine (DA1) receptor agonist, fenoldopam in human vasculature in vivo and in vitro.
  British Journal of Clinical Pharmacology, 1986
• Studies with fenoldopam, a dopamine receptor DA1 agonist, in essential hypertension.
  British Journal of Clinical Pharmacology, 1986
• The DA1 receptor agonist fenoldopam (SK & F 82526) is also an α2-adrenoceptor antagonist
  European Journal of Pharmacology, 1985
• The effect of oral fenoldopam (SKF 82526-J), a peripheral dopamine receptor agonist, on blood pressure and renal function in normal man.
  British Journal of Clinical Pharmacology, 1985
• Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension.
  Circulation, 1984
• Nitroprusside
  Annals of Internal Medicine, 1979